suture trabeculotomy

  • 文章类型: Journal Article
    目的:在1年的随访时间内,比较粘头吻合术加近360度缝合小梁切开术(VST)与粘头吻合术加刚性探针小梁切开术(VT)治疗原发性先天性青光眼(PCG)的疗效和安全性。
    方法:这项连续的回顾性研究纳入了2017年3月至2019年10月3岁内确诊的PCG患者。通过比较术后眼压(IOP)曲线和术后1年的成功率来评估疗效。通过比较术后并发症来评估安全性。抗青光眼药物的数量,还比较了两种手术方法的水平角膜直径(HCD)和杯盘比(C/D)。
    结果:分析了61例患者的90只眼数据。两组的基线参数相似。VST组术后12个月眼压为12.7±4.8mmHg,而VT组为15.8±6.5mmHg。VST组术后6、9、12个月眼压明显低于VT组(p<0.05)。粘头切开术加近360度缝合小梁切开术(VST)仍然是一年完全成功的重要有利因素(93.6%对74.4%,p=0.005),但不合格的一年成功率(97.9%对88.4%,p=0.06)。抗青光眼药物的数量,两组HCD和C/D均降低。两组术后并发症无明显差异。
    结论:在患有PCG的儿童中,在一年的随访中,VST比VT提供更持久的IOP控制,具有类似的安全性。
    OBJECTIVE: To compare the efficacy and safety of viscocanalostomy plus near-360-degree suture trabeculotomy (VST) with viscocanalostomy plus rigid probe trabeculotomy (VT) in treating primary congenital glaucoma (PCG) over a one-year follow-up.
    METHODS: This consecutive retrospective study included patients with PCG confirmed within 3 years of age from March 2017 to October 2019. Efficacy was evaluated by comparing the postoperative intraocular pressure (IOP) curve and the success rate at one year after surgery. Safety was assessed by comparing the postoperative complications. The number of anti-glaucoma agents, horizontal corneal diameter (HCD) and cup-to-disc ratio (C/D) of the two surgical methods were also compared.
    RESULTS: Data of 90 eyes from 61 patients were analysed. The baseline parameters of the two groups were similar. The IOP at 12 months after surgery in the VST group was 12.7 ± 4.8 mmHg, while that in the VT group was 15.8 ± 6.5 mmHg. The IOP at 6, 9 and 12 months postoperatively in the VST group was significantly lower than in the VT group (p < 0.05). Viscocanalostomy plus near-360-degree suture trabeculotomy (VST) remained a significant favourable factor for complete one-year success (93.6% versus 74.4%, p = 0.005) but not qualified one-year success (97.9% versus 88.4%, p = 0.06). The number of anti-glaucoma agents, HCD and C/D were reduced in both groups. Postoperative complications were not significantly different between the two groups.
    CONCLUSIONS: In children with PCG, VST provides a more durable IOP control than VT over the one-year follow-up, with a similar safety profile.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    OBJECTIVE: The aim of this study was to determine the preliminary efficacy and safety of a novel technique for trabeculotomy for the treatment of primary congenital glaucoma (PCG).
    METHODS: This retrospective interventional study was conducted on patients with PCG. Pliability test was performed among 5/0 and 6/0 polypropylene sutures and the flexible illuminated microcatheter. Viscocanalostomy was first performed and the Schlemm\'s canal was identified. Then, suture trabeculotomy was completed except the region for viscocanalostomy. The preoperative and follow-up data were recorded and analyzed. Success criteria were defined as intraocular pressure (IOP) ≤ 21 mmHg without (complete success) or with medications (qualified success).
    RESULTS: 5/0 polypropylene suture was an appropriate option for cannulation of Schlemm\'s canal. A total of 33 eyes from 23 consecutive patients were included with a mean follow-up of 9.3 ± 3.6 months (range 6-18 months). Circumferential cannulation by suture was successfully performed in 28 eyes (84.8%) of 18 patients. Mean IOP decreased from 33.9 ± 9.4 mmHg preoperatively to 10.5 ± 3.5 mmHg at 6 months (p < 0.001) and 11.3 ± 4.1 mmHg at 9 months (p < 0.001). Complete success rate was 92.9% [95% confidence interval (CI:0.83-1.03)] and 87.5% (CI:0.69-1.06) at 6 months and 9 months, respectively. Hyphema was found in 5 eyes (17.9%), all of which were absorbed within 1 week. No other complications were observed.
    CONCLUSIONS: Viscocanalostomy combined with nearly 360-degree suture trabeculotomy as a novel technique controls IOP in patients with PCG without any severe complications. It is suitable for extended applications because of accurate identification of Schlemm\'s canal and low cost.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号